Recent Finacing
Recent Raise
Caribou Biosciences develops CRISPR-Cas platforms using chRDNA RNA–DNA hybrid guides for precise, multiplex genome editing to engineer allogeneic CAR-T/CAR-NK cell therapies and support agricultural, industrial, and research applications.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
